GBA1 and Parkinson disease: As such treatments emerge, it may become important to screen patients with PD for variants in the GBA1 gene, so that precision medicine can be applied, and our data suggest that it will be important to screen for a much broader range of variants than those previously identified as ‘pathogenic’.